ArticleSarcoma2017
Multimodal Approach of Pulmonary Artery Intimal Sarcoma: A Single-Institution Experience.
Article in Sarcoma, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 41 citations in OpenAlex.
- Pulmonary Artery Intimal Sarcoma Successfully Treated With Surgery and Adjuvant Chemotherapy: A Case Report.Clinical case reports · 2026Article
- Pulmonary Artery Sarcoma Study: A Multi-Centre European Society of Thoracic Surgeons Working Group Evaluating Diagnosis, Treatment, and Outcomes.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2026Article
- Primary intimal sarcoma of the pulmonary artery misdiagnosed as acute pulmonary embolism: a case report.Frontiers in oncology · 2026Article
- Pulmonary artery intimal sarcoma in TB-endemic region: A diagnostic challenge.Respiratory medicine case reports · 2026Article
- Pulmonary Artery Intimal Sarcoma: Diagnostic and Surgical Strategy from a Rare Case.Surgical case reports · 2025Article
- Multi-omics analysis revealed potential use of immunotherapy and CDK4/6 inhibitors in intimal sarcoma.Frontiers in immunology · 2025Article
- Pulmonary artery intimal sarcoma: Case report of a patient managed with multimodality treatment and a comprehensive literature review.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024Review
- Thrombus or tumor? A case report of a rare sarcoma entity: intimal sarcoma of the pulmonary arteries.Molecular biology reports · 2024Article
- Spindly reason for a pulmonary embolism.BMJ case reports · 2024Article
- Article
- Pulmonary thromboembolic disease or pulmonary artery intimal sarcoma: Case report and literature review.Oncology letters · 2022Article
- A case report of primary pulmonary artery intimal sarcoma.Radiology case reports · 2022Article
- Pulmonary artery sarcoma: An important mimic of pulmonary embolism-Case reports and literature review.Respirology case reports · 2022Article
- Pedunculated pulmonary artery intimal sarcoma with poor uptake in 18F-FDG PET/CT: A case report.Journal of cardiology cases · 2021Article
- A 51-year-old man with chronic cough and left hilar prominence.Breathe (Sheffield, England) · 2021Article
- Transient Response of Olaparib on Pulmonary Artery Sarcoma Harboring Multiple Homologous Recombinant Repair Gene Alterations.Journal of personalized medicine · 2021Article
- Intimal sarcoma of the pulmonary artery treated with neoadjuvant radiation prior to pulmonary artery resection and reconstruction.Respiratory medicine case reports · 2021Article
- Angiosarcoma of the pulmonary artery mimicking pulmonary thromboembolism.SA journal of radiology · 2021Article
- Misdiagnosis of primary intimal sarcoma of the pulmonary artery as chronic pulmonary embolism: A case report.World journal of clinical cases · 2020Article
- Pulmonary artery intimal sarcoma: a case report and literature review.Respirology case reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPulmonary artery sarcoma (PAS) is a rare tumor, whose therapeutic approach is mainly based on surgery, either pneumonectomy or pulmonary endarterectomy (PEA). The prognosis reported in published series is very poor, with survival of 1.5 months without any kind of treatment. PATIENTS AND
methodsFrom January 2010 to January 2016, 1027 patients were referred to our hospital for symptoms of acute or chronic pulmonary thromboembolic disease. Twelve patients having a confirmed diagnosis of PAS underwent PEA. Median age was 64.5 years. Most patients had a long history of symptoms, having a median time of 7.5 months from onset of symptoms to surgery.
resultsFollowing PEA and cardiopulmonary rehabilitation, 10 patients received conventional chemotherapy with doxorubicin and ifosfamide, starting at a median of 42 days from surgery. Four patients also received radiotherapy. Four patients have died due to disease progression, while 7 are still alive, with 5 being disease-free at 4-55+ months from diagnosis.
conclusionsIn patients with PAS, a multimodal approach including PEA, CT, and RT is feasible but it should be evaluated individually, according to the tumor extension and the patient's clinical condition. Apart from improving quality of life mainly by reducing or delaying symptoms due to PH, it may improve life expectancy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.